CereGate

medical devices

About

CereGate is a German neurotechnology company founded in 2019 and based in Hamburg. The company specializes in developing a Computer-Brain Interface (CBI) platform that facilitates direct communication with the human brain. Their technology is compatible with existing neuromodulation implants, such as Deep Brain Stimulation (DBS) and Spinal Cord Stimulation (SCS) devices, and is designed to enhance the treatment of neurological and psychiatric disorders. Currently, CereGate focuses on improving gait and balance symptoms in Parkinson’s disease patients and addressing vestibular disorders. CereGate’s software platform utilizes advanced neuromodulation technology to modulate neural activity, aiming to restore human senses and improve patients' quality of life. The company has conducted over 85 successful patient trials, demonstrating the effectiveness of their solutions. They are pursuing FDA trials and Breakthrough Device status, highlighting their commitment to innovation. CereGate's technology is adaptable and scalable, making it suitable for various medical conditions and appealing for partnerships in the medtech industry.

Technologies

Gmail Google Apps Apache Mobile Friendly Remote

Keywords

medical equipment manufacturing brain implants neural interfaces neural interface for movement disorders computer-brain interface services neurodiagnostics brain signal enhancement spinal cord stimulator as cbi brain-computer interface neural interface software neurostimulation for sensory restoration non-invasive neural interfaces minimally invasive neurorehabilitation clinical validation neural communication spinal cord stimulator medical equipment and supplies manufacturing neuromodulation b2b neurotechnology brain signal decoding brain-computer communication machine learning neuroprosthetics medical devices brain health neural circuit modulation neuroscience

Location

Munich, Bavaria, Germany, 80539

Related Companies

Companies in the same industry